Elif Ozkirimli
Elif Ozkirimli
Head of Data Science and Advanced Analytics, Roche
Verified email at boun.edu.tr
Cited by
Cited by
DeepDTA: deep drug–target binding affinity prediction
H Öztürk, A Özgür, E Ozkirimli
Bioinformatics 34 (17), i821-i829, 2018
Src kinase activation: A switched electrostatic network
E Ozkirimli, CB Post
Protein Science 15 (5), 1051-1062, 2006
An electrostatic network and long‐range regulation of Src kinases
E Ozkirimli, SS Yadav, WT Miller, CB Post
Protein Science 17 (11), 1871-1880, 2008
Classification of beta-lactamases and penicillin binding proteins using ligand-centric network models
H Öztürk, E Ozkirimli, A Özgür
PloS one 10 (2), e0117874, 2015
Comparison of three perturbation molecular dynamics methods for modeling conformational transitions
H Huang, E Ozkirimli, CB Post
Journal of chemical theory and computation 5 (5), 1304-1314, 2009
Membrane active peptides and their biophysical characterization
FG Avci, B Sariyar Akbulut, E Ozkirimli
Biomolecules 8 (3), 77, 2018
A comparative study of SMILES-based compound similarity functions for drug-target interaction prediction
H Öztürk, E Ozkirimli, A Özgür
BMC bioinformatics 17 (1), 1-11, 2016
Generation of an analog-sensitive Syk tyrosine kinase for the study of signaling dynamics from the B cell antigen receptor
H Oh, E Ozkirimli, K Shah, ML Harrison, RL Geahlen
Journal of Biological Chemistry 282 (46), 33760-33768, 2007
The uptake mechanism of the cell penetrating pVEC peptide
IO Akdag, E Ozkirimli
Alpha7 helix plays an important role in the conformational stability of PTP1B
E Ozkirimli Olmez, B Alakent
Journal of Biomolecular Structure and Dynamics 28 (5), 675-693, 2011
A novel methodology on distributed representations of proteins using their interacting ligands
H Öztürk, E Ozkirimli, A Özgür
Bioinformatics 34 (13), i295-i303, 2018
Exploring chemical space using natural language processing methodologies for drug discovery
H Öztürk, A Özgür, P Schwaller, T Laino, E Ozkirimli
Drug discovery today 25 (4), 689-705, 2020
Response of Escherichia coli to Prolonged Berberine Exposure
N Budeyri Gokgoz, FG Avci, KK Yoneten, B Alaybeyoglu, E Ozkirimli, ...
Microbial Drug Resistance 23 (5), 531-544, 2017
Protein-peptide interactions revolutionize drug development
E Ozkirimli Olmez, B Sariyar Akbulut
Binding Protein, 49, 2012
Communication between the active site and the allosteric site in class A beta-lactamases
D Meneksedag, A Dogan, P Kanlikilicer, E Ozkirimli
Computational biology and chemistry 43, 1-10, 2013
WideDTA: prediction of drug-target binding affinity
H Öztürk, E Ozkirimli, A Özgür
arXiv preprint arXiv:1902.04166, 2019
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors
U Deniz, E Ozkirimli, KO Ulgen
Journal of Molecular Graphics and Modelling 63, 110-124, 2016
Targeting the Akt1 allosteric site to identify novel scaffolds through virtual screening
OG Yilmaz, E Ozkirimli Olmez, KO Ulgen
Computational biology and chemistry 48, 1-13, 2014
An evolutionarily conserved allosteric site modulates beta-lactamase activity
FG Avci, FE Altinisik, D Vardar Ulu, E Ozkirimli Olmez, B Sariyar Akbulut
Journal of enzyme inhibition and medicinal chemistry 31 (sup3), 33-40, 2016
A novel chimeric peptide with antimicrobial activity
B Alaybeyoglu, B Sariyar Akbulut, E Ozkirimli
Journal of Peptide Science 21 (4), 294-301, 2015
The system can't perform the operation now. Try again later.
Articles 1–20